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ABSTRACT; 
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multidrug 
resistance tuberculosis (MDR-TB) continues to be a serious threat to the current global tuberculosis control 
effort. Failure to control MDR-TB may lead to another era with TB being regarded as a fatal disease. Materials 
and Method; One hundred forty one cases confirmed MDR-TB patient by of either gender aged less than 60 
years who were newly diagnosed or who were previously diagnosed cases were enrolled in this descriptive 
study. Demographic, socioeconomic, clinical as well as laboratory data were recorded for each patient by trained 
data collector. The data was collected through pre-tested close ended questionnaire. Drug resistant cases was 
labeled according to sputum culture Sensitivity report and GeneXpert for MTB and were assessed for different 
factors for MDR. Results; Our study comprised of 141 study cases of MDR TB, 71 (50.4%) were male patients 
and 70 (49.6 %) were female patients. Mean age of our study cases was 39.99 ± 9.15 years One hundred and five 
(74.5%) of our study cases were married while 36 (25.5%) were unmarried. Majority of our study cases were 
less educated as 47 (33.3%) were illiterate and 78 (55.3%) were having primary level of education. Majority of 
our study cases were living in slum areas and were having poor socioeconomic status as 77 (54.6%) were having 
their family income less than Rs. 10, 000 per month. Previous history of TB was present in 99 (70.2 %) of our 
study cases. Good compliance with the treatment was present in only 28 (19.9%) of our study cases. History of 
close contact with TB patient was reported by 92 (65.2%) of our study cases, 20 (14.2%) were defaulters and 42 
(29.8%) presented with treatment failure. History of HIV infection was zero in our study. Conclusion; Previous 
history of Tuberculosis with poor compliance with drug therapy was the major risk factor for the development of 
MDR TB in our study. History of close contact with TB patients was another important risk factor in the 
development of MDR TB. Other important risk factors were previous history of tuberculosis infection, living in 
urban slum areas, poor educational status and poor socioeconomic status were more common.  
Keywords; Multidrug resistance, Tuberculosis, Risk factors.  
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INTRODUCTION 
Tuberculosis is a major infectious health problem; over two billion people are affected by this disease annually 
throughout the world. TB represents more than a quarter of world’s preventable death1.Multi Drug Resistant 
Tuberculosis (MDR-TB) prevalence in South East Asia is estimated as 2.8% (95% CI, 1.9 to 3.6) among new 
cases and 18.58% (95% CI, 13.3 to 24.3) among previous treated cases
2
 . According to WHO Global TB report 
2011, Pakistan ranks 5th among 22 high burden countries in TB and 4th among 27th high Multi Drug Resistant 
Tuberculosis (MDR-TB) countries,the percentage of Multi Drug Resistant Tuberculosis (MDR-TB) is 3.4 among 
new tuberculosis cases and 21 among retreated cases. It is realized that there is rising incidence of Drug 
Resistant Tuberculosis. 
Currently Multi Drug Resistant Tuberculosis (MDR-TB) is considered as one of most important threats to TB 
control effort through the world
3. According to WHO’s fourth global report in Anti-TB drug resistant, there were 
an estimated 4.8% of all new cases which were diagnosed as Multi Drug Resistant Tuberculosis, greatest 
numbers of such cases reported from Pakistan, China, India, and Russia
4
. From individual perspective, 
Treatment failures with first line Rifimpicine containing regimens and contact of Multi Drug Resistant 
Tuberculosis case have highest rates of resistant
5
. Despite a comparatively higher disease prevalence of this 
disease amounting to 263/100,000 population among its neighboring countries, Pakistan Lacks the updated 
regional information about the Drug resistant TB
6
. A recently published study indicated Multi Drug Resistant 
Tuberculosis rate of 1.8% amongst untreated patients presenting to TB clinics within Pakistan
7
. 
Multi Drug Resistant Tuberculosis is microbial, clinical and programmatic issue. From microbiological 
perspective, resistant is caused by a genetic mutation that makes a drug ineffective. Percentages of various risk 
factors for MDR-TB are  
1) Previous history of tuberculosis (82.6%)
 8
.  
2) Previous history of treatment of tuberculosis (100%)
 9
,  out of which 67 % had missed a few weeks drugs 
during this previous treatment and 13% had been marked as defaulter and 20% had treatment failure
 
.  
3) Poor compliance (60.9%)
8
.  
4) History of contact with MDR-TB patients ( 42.6%)
 10
.  
5) HIV (6.2%)
9
.   
These factors have contributed to poor patient compliance and future increasing prevalence of Multi-Drug 
Resistant Tuberculosis (MDR-TB) as well as emergence of Extensive Drug Resistant Tuberculosis (XDR-TB). 
Materials and Method 
One hundred forty one cases confirmed MDR-TB patient by Culture and DST and GeneXpert for MTB of either 
gender aged less than 60 years who were newly diagnosed or who were previously diagnosed cases were 
enrolled in this descriptive study.  Patients who had diabetes, HIV, asthma, incomplete clinical record, 
malignancies and hypertension were not included in this study. Demographic, socioeconomic, clinical as well as 
laboratory data were recorded for each patient by trained data collector. The data was collected through pre-
tested close ended questionnaire. Drug resistant cases was labeled according to sputum culture Sensitivity report 
and GeneXpert for MTB. The data was entered in statistical program for social sciences (SPSS) version 18.   
Results; 
Our study comprised of 141 study cases of MDR TB who met inclusion and exclusion criteria of this 
study. Of these 141 study cases, 71 (50.4%) were male patients and 70 (49.6 %) were female patients. Mean age 
of our study cases was 39.99 ± 9.15 years (with minimum age was 25 years while maximum age was 53 years). 
Our study results have indicated that majority of our study cases i.e. 78 (55.3%) were less than 40 years of age. 
One hundred and five (74.5%) of our study cases were married while 36 (25.5%) were unmarried. Majority of 
our study cases were less educated as 47 (33.3%) were illiterate and 78 (55.3%) were having primary level of 
education. Majority of our study cases were living in slum areas and were having poor socioeconomic status as 
77 (54.6%) were having their family income less than Rs. 10, 000 per month. Previous history of TB was present 
in 99 (70.2 %) of our study cases. Good compliance with the treatment was present in only 28 (19.9%) of our 
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study cases. History of close contact with TB patient was reported by 92 (65.2%) of our study cases, 20 (14.2%) 
were defaulters and 42 (29.8%) presented with treatment failure. History of HIV infection was zero in our study.  
 
Table No. 1 
Stratification of risk factors with regards to gender. 
(n=141) 
 
Risk factors 
Gender  
P – value  
Male 
(n=71) 
Female 
(n=70) 
Previous history 
of TB 
Yes 43 56  
0.016 No 28 14 
History of 
treatment of TB 
Yes 28 29  
0.865 No 43 41 
 
Compliance  
Good 28 00  
0.000 Poor 43 70 
Close contacts Yes 71 21  
0.000 No 00 49 
 
Defaulters 
Yes 02 18  
0.000 No 69 52 
 
Treatment failure 
Yes 28 14  
0.016 No 43 56 
 
 
 
DISCUSSION; 
Multidrug-resistant tuberculosis (MDR-TB), which is defined as TB caused by strains of 
Mycobacterium tuberculosis (MTB) that are resistant to at least isoniazid (INH) and rifampicin (RFP), is a form 
of TB infection linked with high morbidity and mortality, and it is of great importance to the National TB 
Control Program (NTP). MDR-TB results from primary infection with resistant bacteria (primary MDR-TB), or 
it may develop in the course of a patient's treatment (acquired MDR-TB) 
11-19
. 
Our study comprised of 141 study cases of MDR TB who met inclusion and exclusion criteria of this 
study. Of these 141 study cases, 71 (50.4%) were male patients and 70 (49.6 %) were female patients. Rifat et al 
17
 from Bangladesh reported 60 % male predominance in their study, which is bit high proportion than that of 
our findings. Mulu et al 
18
 reported 57 % male patients having MDR TB, these findings are close to our study 
results. Mean age of our study cases was 39.99 ± 9.15 years (with minimum age was 25 years while maximum 
age was 53 years). Our study results have indicated that majority of our study cases i.e. 78 (55.3%) were less 
than 40 years of age. Rifat et al 
17
 from Bangladesh reported 37 years mean age of the patients with MDR TB, 
which is close to our study results. Mulu et al 
18
 also reported MDR TB being more common in young patients 
with ages less than 45 years which is in accordance with our study results. Li et al 
11
 reported 37.59 years mean 
age, which are close to that of ours study results. One hundred and five (74.5%) of our study cases were married 
while 36 (25.5%) were unmarried. Mulu et al 
18
 reported 37 % MDR TB patients were married, these findings 
are similar to that of our study results. In our study, 66 % of our patients were from Urban areas while a study 
conducted by Mulu et al 
18
 reported 74 % patients from Urban areas, these findings of Mulu et al are similar to 
that of our study results. Similar findings were made by Rifat et al
17
. 
 Majority of our study cases were less educated as 47 (33.3%) were illiterate and 78 (55.3%) were 
having primary level of education. Rifat et al 
17
 from Bangladesh also reported MDR TB being more prevalent in 
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less educated patients living in slum areas, these findings support our study results. Similar results have been 
reported by Mulu et al. 
18
 Majority of our study cases were living in slum areas and were having poor 
socioeconomic status as 77 (54.6%) were having their family income less than Rs. 10, 000 per month.  Rifat et al 
17
 reported MDR TB was associated with poor socio-economic status which is in accordance with our study 
results. Wang et al 
19
 from China reported similar findings of MDR TB being more common in patients having 
lower socio-economics. Similar results have been reported by Mulu et al 
18
.  
Previous history of TB was present in 99 (70.2 %) of our study cases. A study conducted by Li et al 
11
 
reported 44% previous history of TB in their patients which is quite low than that of our study results. Different 
studies reported from all over the world have associated MDR TB with poor compliance with previous treatment 
of TB in the development of MDR 
11-19
. Similar findings have been observed in our study where poor 
compliance with the treatment was more than 80%, good compliance with the treatment was present in only 28 
(19.9%) of our study cases. Similar results have been reported by Rifat et al, Mulu et al and Li  et al 
11, 17, 18
.  
History of close contact with TB patient was reported by 92 (65.2%) of our study cases while Rifat et al 
17
 
reported 39 % history of close contact with TB patients, 20 (14.2%) were defaulters and 42 (29.8%) presented 
with treatment failure. Mulu et al 
18
 reported 88 % defaulter rates in these patients. History of HIV infection was 
zero in our study, while different studies conducted in different parts of the world have found high frequencies of 
HIV infections among targeted population.  
CONCLUSION; 
Previous history of Tuberculosis with poor compliance with drug therapy was the major risk factor for the 
development of MDR TB in our study. History of close contact with TB patients was another important risk 
factor in the development of MDR TB. Other important risk factors were previous history of tuberculosis 
infection, living in urban slum areas, poor educational status and poor socioeconomic status were more common.  
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